Shares of marijuana company Canopy Growth were up over 6% on Wednesday after the company said its Spectrum Cannabis unit is teaming up with the Ontario Long Term Care Association (OLTCA) for a pilot that will assess the use of medical marijuana in treating pain and cognitive function in seniors.

OLTCA and Canopy will recruit a group of long-term care homes to perform the study while evaluating quality of life outcomes, caregiver stress and the economic benefits of cannabis adoption. The six-month study will be conducted at some of Ontario’s 630 long-term care homes.

“There is clearly an interest in the long-term care space to explore medical cannabis as an alternative to traditional medications for pain and degenerative cognitive function,” said Canopy co-Chief Executive Mark Zekulin.

“The pilot study we’ve announced today is the first step in developing an evidence-based, best practice approach to medical cannabis that will result in consistent care for thousands of seniors and ultimately improve quality of life and outcomes in long-term care homes.”

Medical cannabis is currently prescribed for residents as appropriate, but it’s still an emerging area,” says Candace Chartier , CEO, Ontario Long Term Care Association.

“Through this partnership and pilot study, we hope to provide more clarity to long-term care clinicians and frontline staff about the use of medical cannabis for residents.”

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Marijuana Website Herb Just Raised Over $4M
30 August 2017
The People of Uruguay Can Now Buy Marijuana From Pharmacies
19 July 2017
Oregon Will Pause Marijuana License Application Acceptance
31 May 2018